Prostate Cancer Manufacturers, Suppliers & Companies (Medical Specialties)
-
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
Since its inception, Zenflow has always put the patient first. Founded out of the Stanford Byers Center for Biodesign, we are a passionate and innovative team that brings extensive experience from successful startups and leading multinational ...
-
Manufacturerbased in Plymouth, MASSACHUSETTS (USA)
We started Medical Monofilament in 1999 in order to produce the best sensory testing monofilament available. Our goal was and still is to help decrease the incidence of diabetic foot ulcerations and amputations for diabetic patients at risk. For ...
-
Technologybased in Maple Grove, MINNESOTA (USA)
Francis Medical is developing novel, disruptive therapeutic solutions to treat prostate, kidney and bladder cancer. Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer, ...
Francis Medical - Thermal Water Vapor Energy Technology
Thermal water vapor energy technology is a breakthrough therapy designed to use phase shift energy, stored in sterile water vapor, to convectively transfer thermal energy to cancerous tissue, causing cell death. Through this process, ...
CONTACT SUPPLIER -
Technologybased in Ettlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
-
Technologybased in Woburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Aphios - Model APH-0701 - Prostate Cancer Prevalence and Demographics
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed annually. In the U.S. this year, 1 in 6 males will develop the disease ...
CONTACT SUPPLIER -
Manufacturerbased in Norcross, GEORGIA (US) (USA)
For more than 20 years, CP Medical has been a leading U.S. manufacturer of surgical solutions, specializing in products for wound closure as well as for specialty surgical applications. Our deep-rooted experience and innovative solutions for ...
-
Manufacturerbased in Toronto, ONTARIO (CANADA)
Focal Healthcare is a world-class medical device company dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment. Throughout his career, Chicuong realized that there were many inefficiencies, ...
Fusion - Model Bx - Semi-Robotic Arm System
Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm of the Fusion Bx allows you to effortlessly maneuver ...
CONTACT SUPPLIER -
Manufacturerbased in Miami, FLORIDA (USA)
Veru is a biotechnology company focused on developing novel medicines for COVID-19, additional ARDS-related diseases, and for breast and prostate cancers. Veru is a Wisconsin corporation and is the successor to The Wisconsin Pharmacal Company, Inc. ...
-
Manufacturerbased in Bellaire, TEXAS (USA)
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient care through accurate image-guided procedures. The company’s core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has ...
Sirius - Low Dose Rate (LDR) Brachytherapy
“Permanent prostate brachytherapy dosimetry based only on MRI using positive contrast MRI markers [Sirius®] is feasible, accurate, and reduces the uncertainties arising from CT-MRI fusion abating the need for postimplant multimodality ...
CONTACT SUPPLIER -
Manufacturerbased in Carlsbad, CALIFORNIA (USA)
Qualigen is a biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack diagnostic platform. The FastPack line of FDA-cleared and ...
Model QN-302 - G4 Binders As Potent Selective Transcription Inhibitors
Qualigen licensed the G4 selective transcription inhibitor platform from University College London (UCL) in 2022. The licensed technology comprises lead compound QN-302 (formerly SOP1812) and back-up compounds that target regulatory regions of ...
CONTACT SUPPLIER -
Manufacturerbased in Redwood City, CALIFORNIA (USA)
Auris Health was acquired by Ethicon, part of the Johnson & Johnson Medical Devices Companies, in 2019. Over the past 50 years, the introduction of new technologies has ushered in the era of minimally invasive techniques and procedures. Despite ...
-
Technologybased in Silicon Valley, CALIFORNIA (USA)
Da Zen Theranostics, Inc. (Da Zen) has developed revolutionary therapies for cancer detection, imaging, and treatment in order to prolong survival and improve quality of life for patients with cancer. The innovative research at Da Zen has led to the ...
-
Manufacturerbased in Vaulx-en-Velin, FRANCE
Global leader in therapeutic ultrasound and present in the market for more than 35 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. EDAP TMS ...
ESWL Sonolith Training
Sonolith® training is entirely performed at the urologist's clinical site with an EDAP TMS Application Engineer assisting the urologist on several ...
CONTACT SUPPLIER -
Manufacturerbased in Markham, ONTARIO (CANADA)
Exact Imaging has an experienced management team that has together and individually successfully launched multiple companies and products into global markets, developed global teams and commercial infrastructures, and achieved multiple liquidity ...
ExactVu - Micro-Ultrasound System
ExactVu micro-ultrasound system for targeted biopsies for prostate cancer. ...
CONTACT SUPPLIER -
Manufacturerbased in Milan, ITALY
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,587 employees and annual total consolidated revenues of around 1,4 billion euros, 89% of which from international sales. In the ...
-
Manufacturerbased in Garching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
-
Manufacturerbased in Beverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
Cellanyx - Novel Phenotypic Test
Cellanyx and clinical collaborators have published (hover popup: URL to Urology 2018, Albala et.al.) the first Cellanyx and clinical collaborators have published (hover popup: URL to Urology 2018, Albala et.al.) the first studies demonstrating the ...
CONTACT SUPPLIER -
Technologybased in Reno, NEVADA (USA)
DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...
-
Manufacturerbased in Sunnyvale, CALIFORNIA (USA)
The Prodeon Medical, Inc. initiative was started in 2016 with the mission of transforming the approach to treating lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH). The company has designed a promising new ...
Expander-2 - Benign Prostatic Hyperplasia (BPH)
Struggling with lower urinary tract symptoms related to benign prostatic hyperplasia (BPH)? Approximately, 60% of men over the age of 60 and up to 80% of men overall, will eventually develop BPH with LUTS, of which 30% will require ...
CONTACT SUPPLIER -
Manufacturerbased in St.-Laurent, QUEBEC (CANADA)
Nymox Pharmaceutical Corporation specializes in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the rapidly aging male population in developed economies. The ...
Nymox - Fexapotide Triflutate - Protein Injectable for Benign Prostatic Hyperplasia
Fexapotide Triflutate is a protein injectable for benign prostatic hyperplasia (prostate enlargement, "BPH") and for low grade localized prostate cancer. It has been designed to be administered in the urologist's office in a simple injection that ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you